Zurcher Kantonalbank Zurich Cantonalbank Has $1.92 Million Position in Merit Medical Systems, Inc. (NASDAQ:MMSI)

Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) by 23.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 19,846 shares of the medical instruments supplier's stock after acquiring an additional 3,819 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank's holdings in Merit Medical Systems were worth $1,920,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the company. Atria Investments Inc increased its stake in shares of Merit Medical Systems by 25.5% in the third quarter. Atria Investments Inc now owns 10,461 shares of the medical instruments supplier's stock valued at $1,034,000 after purchasing an additional 2,127 shares during the period. Natixis Advisors LLC increased its stake in shares of Merit Medical Systems by 1.5% during the third quarter. Natixis Advisors LLC now owns 67,544 shares of the medical instruments supplier's stock valued at $6,675,000 after acquiring an additional 1,009 shares during the period. Quest Partners LLC increased its stake in shares of Merit Medical Systems by 92.6% during the third quarter. Quest Partners LLC now owns 11,843 shares of the medical instruments supplier's stock valued at $1,170,000 after acquiring an additional 5,695 shares during the period. Pathstone Holdings LLC increased its stake in shares of Merit Medical Systems by 20.1% during the third quarter. Pathstone Holdings LLC now owns 34,950 shares of the medical instruments supplier's stock valued at $3,454,000 after acquiring an additional 5,844 shares during the period. Finally, Jennison Associates LLC acquired a new position in shares of Merit Medical Systems during the third quarter valued at approximately $935,000. Institutional investors and hedge funds own 99.66% of the company's stock.

Remove Ads

Merit Medical Systems Stock Up 0.4 %

Shares of Merit Medical Systems stock traded up $0.40 during midday trading on Friday, reaching $101.68. 1,217,700 shares of the company's stock traded hands, compared to its average volume of 424,256. The company has a market cap of $5.98 billion, a price-to-earnings ratio of 49.84, a price-to-earnings-growth ratio of 2.34 and a beta of 0.91. Merit Medical Systems, Inc. has a 52 week low of $70.70 and a 52 week high of $111.45. The company has a debt-to-equity ratio of 0.57, a quick ratio of 3.82 and a current ratio of 5.36. The company's 50 day simple moving average is $103.82 and its 200 day simple moving average is $100.71.

Analyst Ratings Changes

MMSI has been the topic of a number of research analyst reports. Needham & Company LLC lowered their price objective on shares of Merit Medical Systems from $122.00 to $116.00 and set a "buy" rating on the stock in a research note on Wednesday, February 26th. Raymond James raised their target price on shares of Merit Medical Systems from $105.00 to $110.00 and gave the stock an "outperform" rating in a report on Tuesday, December 31st. Piper Sandler restated an "overweight" rating and set a $116.00 target price (up from $114.00) on shares of Merit Medical Systems in a report on Wednesday, January 29th. Barrington Research reduced their target price on shares of Merit Medical Systems from $115.00 to $111.00 and set an "outperform" rating for the company in a report on Wednesday, February 26th. Finally, Wells Fargo & Company reduced their target price on shares of Merit Medical Systems from $120.00 to $117.00 and set an "overweight" rating for the company in a report on Wednesday, February 26th. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $110.78.

Insider Buying and Selling

In related news, CFO Raul Jr. Parra sold 12,451 shares of Merit Medical Systems stock in a transaction on Friday, February 28th. The shares were sold at an average price of $98.81, for a total value of $1,230,283.31. Following the transaction, the chief financial officer now owns 24,201 shares in the company, valued at $2,391,300.81. This trade represents a 33.97 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Brian G. Lloyd sold 25,000 shares of Merit Medical Systems stock in a transaction on Friday, February 28th. The stock was sold at an average price of $99.50, for a total transaction of $2,487,500.00. Following the completion of the transaction, the insider now owns 38,993 shares in the company, valued at $3,879,803.50. This trade represents a 39.07 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 109,132 shares of company stock worth $11,139,521 in the last quarter. 3.70% of the stock is currently owned by company insiders.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.